Interventional pain management

SPR Therapeutics’ 14-Month Data from Multicenter Low Back Pain Trial Demonstrates Significant, Durable Impacts on Pain Intensity, Disability, and Pain Interference

Retrieved on: 
Thursday, March 16, 2023
The Retreat, SPR, SPRINT, Quality of life, Therapy, MD, Trial of the century, Patient, Interventional pain management, Itch, Pain, Central nervous system, PNS, Clinical trial, Doctor of Philosophy, SIS, Chronic pain, Pharmaceutical industry, Nursing, Research

“Some of this study’s most important findings are the continued durability and impacts beyond the 60-day SPRINT® PNS treatment period.

Key Points: 
  • “Some of this study’s most important findings are the continued durability and impacts beyond the 60-day SPRINT® PNS treatment period.
  • In addition, 58 percent of participants had clinically meaningful improvement in two or more outcomes at 14 months.
  • 75 percent of participants who reported taking opioids at baseline reported reductions in opioid consumption in the months after PNS.
  • The most common adverse events were mild skin irritation or pruritis at the bandage or stimulator’s mounting pad.

American Pain Consortium Acquires Indiana Pain Centers Evansville, a JCAHO accredited Ambulatory Surgery Center.

Retrieved on: 
Monday, January 30, 2023
Injection, Joint Commission, CFP, Neck pain, Gold, APC, North American Neuromodulation Society, Interventional pain management, Human, Gold Seal, Spinal stenosis, Tam's Gold Seal Drugs, Health, Rehabilitation, CRPS, Pain management, ASC, Accreditation, Physician, Patient, JCAHO, Piriformis syndrome, Acquisition, Neuropathic pain, Injury, Degenerative disc disease, Chronic pain, Accident, Physical medicine and rehabilitation, Nursing, Dentistry

EVANSVILLE, Ind., Jan. 30, 2023 /PRNewswire/ -- American Pain Consortium (APC) is pleased to announce their latest expansion with the purchase of Indiana Pain Centers Evansville, a JCAHO accredited Ambulatory Surgery Center (ASC) in Evansville, IN.

Key Points: 
  • EVANSVILLE, Ind., Jan. 30, 2023 /PRNewswire/ -- American Pain Consortium (APC) is pleased to announce their latest expansion with the purchase of Indiana Pain Centers Evansville, a JCAHO accredited Ambulatory Surgery Center (ASC) in Evansville, IN.
  • The addition of Indiana Pain Centers Evansville ASC increases the total number of Indiana surgery centers to four and creates access to a larger suite of interventional pain management therapies locally in Evansville.
  • Indiana Pain Centers Evansville ASC is led by Dr. Mansoor Khan who is fellowship trained and board certified in Physical Medicine & Rehabilitation with added qualifications in Interventional Pain Management.
  • This accreditation further demonstrates Indiana Pain Centers Evansville, Center for Pain, and American Pain Consortiums dedication to providing the highest quality of interventional pain care.

Dr. Ameer Ali Joins Physician Partners of America- Dallas, TX

Retrieved on: 
Friday, January 13, 2023
Texas Medical Association, Rehabilitation, Partner, Cell biology, Physician, Rutgers University, Pain, Physical medicine and rehabilitation, Quality of life, Vertebral compression fracture, American Society of Interventional Pain Physicians, Patient, Suite, American Academy, Radiofrequency ablation, Human musculoskeletal system, North American Spine Society, Augmented fifth, Interventional pain management, Medicine, Medical imaging

DALLAS, Jan. 13, 2023 /PRNewswire-PRWeb/ -- Physician Partners of America (PPOA) is pleased to announce that interventional pain management specialist Ameer Ali, M.D., has joined the company's North Dallas, Texas pain management practice. He began seeing patients on January 3 at the office, located at 7515 Greenville Ave, Suite 500, Dallas, TX 75231.

Key Points: 
  • DALLAS, Jan. 13, 2023 /PRNewswire-PRWeb/ -- Physician Partners of America (PPOA) is pleased to announce that interventional pain management specialist Ameer Ali, M.D., has joined the company's North Dallas, Texas pain management practice.
  • He began seeing patients on January 3 at the office, located at 7515 Greenville Ave, Suite 500, Dallas, TX 75231.
  • Dr. Ameer Ali is a warm-hearted, board-certified, specialized Spine Care fellowship trained Interventional Pain Management Physician.
  • Dr. Ali enthusiastically focuses on providing superlative treatment which is of the essence for the appropriate management of these painful conditions.

Aurora Spine Corporation Announces Positive Interim Results from Clinical Study using ZIP™ MIS Interspinous Fusion System

Retrieved on: 
Thursday, October 27, 2022
ASG, Society, Trial of the century, Safety, ASPN, Physician, TSX Venture Exchange, Lumbar spinal stenosis, ZIP, Patient, DRS, Risk, Quality of life, News, CA, GLOBE, Surgeon, Low back pain, Interventional pain management, Comprehensive, Society of Chest Pain Centers, Solution, Dentistry, Medical device, Pain

CARLSBAD, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced positive interim results from a clinical study using the ZIP MIS Interspinous Fusion System.

Key Points: 
  • CARLSBAD, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced positive interim results from a clinical study using the ZIP MIS Interspinous Fusion System.
  • The publication also demonstrated that the use of the ZIP device was both effective and safe at the 3-month follow-up.
  • This study remains active and enrollment is continuing, with more follow-up data expected in the future as more patient data is compiled.
  • The study included results gathered from 11 doctors and was conducted on behalf of Aurora Spine to determine the utility of using interspinous fusion devices as a fusion therapy for the treatment of lumbar spinal stenosis.

NANISX LLC To Focus On ASC Spine Surgeries Hires Ex-Medtronic David Flickinger MBA As New CEO

Retrieved on: 
Tuesday, September 27, 2022
Adoption, Neurosurgery, EBITDA, ASC, Company, Health, Social media, Patient, IPO, CEO, LES, MDT, Platoon, Semper Fidelis (march), Spine, Leadership, Ecosystem, Infantry, IPM, Interventional pain management, Education, Dentistry, NuVasive, Medtronic

MALDEN, Mass., Sept. 27, 2022 /PRNewswire-PRWeb/ -- Effective September 15, 2022 NANISX LLC, a spine medical device company excelling in developing less exposure surgery (LES) technologies in spine surgeries for ambulatory surgery centers (ASC) has announced that the firm has appointed former Medtronic, and Nuvasive sales executive, David Flickinger MBA as their new Chief Executive Officer (CEO).

Key Points: 
  • KICVentures Group hires new CEO David Flickinger MBA to lead NANISX LLC, a spine medical device company excelling in developing patented and innovative less exposure surgery (LES) technologies for spine surgery in ambulatory surgery centers (ASC).
  • NANISX LLC is privately owned by the KICVentures Group and is a spine medical device company excelling in developing less exposure surgery (LES) technologies in spine surgeries for ambulatory surgery centers (ASC).
  • NANISX is formed from the merger of NanoFUSE Biologics LLC, Inspan LLC and Sacrix LLC.
  • NANISX cross markets to Interventional Pain Management (IPM), Orthopedic spine surgeons and Neurosurgeons under NANISX Pain division and NANISX Ortho-Neuro division.

Pain Specialists of America is the First in Texas to Integrate New Spinal Cord Stimulation Device; Provides Tailored Relief to Multiple Pain Areas and Options for Evolving Pain Conditions

Retrieved on: 
Monday, September 26, 2022
PSA, Spinal cord, Risk, Brain, MD, Food, Patient, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Travel, Cleveland Clinic, Physician, Pain, Technology, Cleveland, Quality of life, Harvard Medical School, SCS, I-35, Interventional pain management, Chronic pain, Medical imaging, Medicine, Dentistry, Central Texas

AUSTIN, Texas, Sept. 26, 2022 /PRNewswire/ -- Pain Specialists of America (PSA) announced it is integrating the new Proclaim™ Plus spinal cord stimulation (SCS) system featuring FlexBurst360™ therapy for patients receiving neuromodulation therapy for chronic pain. Recently approved by the U.S. Food and Drug Administration, the next generation of Abbott's proprietary BurstDR™ stimulation, FlexBurst360 therapy offers pain coverage across up to six areas of the trunk and/or limbs and enables adaptable programming that can be adjusted as a person's therapeutic needs evolve.

Key Points: 
  • PSA's leading team of interventional pain experts stay at the forefront of innovation and technology to give their patients the best care possible.
  • This new facility is the fourth surgery center spanning the footprint of 15 locations to serve the Central Texas market.
  • The system allows doctors control over multiple independent BurstDR stimulation areas to provide broader pain coverage without overstimulation risk.
  • About Pain Specialists of America:
    Pain Specialists of America is an interventional pain management group with highly educated, double and triple-board-certified pain physicians.

IBJI Welcomes Five New Physicians with Multiple Specialties

Retrieved on: 
Tuesday, September 13, 2022
DPM, Knee, ACL, Spinal stenosis, Hip, Arthritis, MD, National Center for Spinal Disorders, Patient, Sports medicine, Shoulder, Foot, Fracture, Elbow, Trauma, Spinal disc herniation, Pain, Quality of life, Instability, Shoulder arthritis, Anesthesiology, Pain management, Multimedia, University, Interventional pain management, Dentistry, Sports equipment

He has expertise in sports medicine, trauma, nerve procedures, ankle replacement, reconstructive surgery, and diabetic limb salvage and wound care.

Key Points: 
  • He has expertise in sports medicine, trauma, nerve procedures, ankle replacement, reconstructive surgery, and diabetic limb salvage and wound care.
  • Dr. Chioffe believes in patient-centered care and creates individual treatment plans for his patients, starting with nonoperative measures.
  • If surgery is necessary, he employs the latest technologies using computerized navigation to ensure the best minimally invasive outcomes for his patients.
  • Ryan E. Harold, MD is an orthopedic surgeon with fellowship training in shoulder & elbow, and hand surgery.

Dr Kingsley R Chin steps down as CEO of NanoFuse Biologics LLC after merger with NANISX LLC

Retrieved on: 
Friday, September 9, 2022
Health care, Johnson & Johnson, CEO, Technology, EBITDA, DePuy, DBM, Solution, Orthopedic surgery, Ambulatory Surgery Center Association, 3D ultrasound, Spine, Phosphate, IPO, IPM, Synthetic, CFO, Interventional pain management, FDA, LLC, Elective surgery, ASC, Acquisition, Ceramic, Pharmaceutical industry, Calcium, Neurosurgery, Sodium

MALDEN, Mass., Sept. 9, 2022 /PRNewswire-PRWeb/ -- NanoFUSE Biologics is the world's only FDA-approved synthetic fiber-based bioactive glass combined with demineralized bone matrix (DBM) for regenerative bone formation, promoting fusion and bone healing. NanoFUSE, when combined with an aqueous body fluid, forms a 3D ultra porous calcium hydroxyapatite layer for bone formation in as early as 24 hours. This reaction leads to the immediate release of Calcium, Sodium, Silica and Phosphate ions and the angiogenic/osteogenic response. Healthcare investment firm focused on ambulatory surgery center (ASC) spine surgery, KICVentures Group, owns NanoFuse Biologics LLC, Inspan LLC and Sacrix LLC and merged its holdings into NANISX LLC as of August 15th, 2022.

Key Points: 
  • NanoFUSE Biologics is the world's only FDA-approved fiber-based synthetic bioactive glass combined with demineralized bone matrix (DBM) for regenerative bone formation, promoting fusion and bone healing.
  • NanoFUSE Biologics LLC merged with NANISX LLC on August 15th, 2022 to offer a combined technology platform to Ambulatory Surgery Centers (ASC).
  • Healthcare investment firm focused on ambulatory surgery center (ASC) spine surgery, KICVentures Group, owns NanoFuse Biologics LLC, Inspan LLC and Sacrix LLC and merged its holdings into NANISX LLC as of August 15th, 2022.
  • NanoFUSE Biologics LLC is privately owned by the KICVentures Group and has a proprietary fiber-based synthetic bioactive glass.

Padma Doniparthi, MD, DABA, DABPM, AAHPC, Joins Pain Specialists of America in Temple and Georgetown, TX

Retrieved on: 
Tuesday, September 6, 2022
Harvard Medical School, Chronic pain, Patient, PSA, American Board of Commissioners for Foreign Missions, Medical college, Medical College of Wisconsin, Cleveland Clinic, Overalls, Palliative care, Physician, American Society of Interventional Pain Physicians, Cleveland, Quality of life, MD, Interventional pain management, Pain, Hospice, Baylor University Medical Center, Pain management, I-35, Health, King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College, Medicine, Dentistry, Internship, University of Texas Southwestern Medical Center, Anesthesiology

Dr. Doniparthi is a best-in-class, triple board-certified interventional pain management physician with over 20 years of excellence.

Key Points: 
  • Dr. Doniparthi is a best-in-class, triple board-certified interventional pain management physician with over 20 years of excellence.
  • She has relocated to the Georgetown community from Brookfield, WI, where she practiced interventional pain medicine.
  • Dr. Padma Doniparthi is a diplomate of the American Board of Anesthesiology, Pain Management and Hospice and Palliative Care.
  • About Pain Specialists of America:
    Pain Specialists of America is an interventional pain management group with highly educated, double and triple-board-certified pain physicians.

PAINWeek 2022 Announces the Return of the International Pelvic Pain Society Track on September 8

Retrieved on: 
Thursday, August 18, 2022
Chronic pain, Endometriosis, Dentist, MS, Prevalence, Female, American Society of Interventional Pain Physicians, Physical therapy, JAMA, Knowledge, Society, Pain, Ultimate Medical Academy, Patient, Review, ACCME, Practitioner, Partnership, Awareness, Laparoscopy, Doctor of Philosophy, Great, Health coaching, Interventional pain management, ANCC, Cosmopolitan of Las Vegas, Menstruation, Pelvic pain, CPP, The Cosmopolitan, CME, Education, Accreditation, Conference, Neurology, Health, Pharmacist, Birth control, Medical imaging, Psychedelic drug, Global, MD, Woman

MONTCLAIR, N.J., Aug. 18, 2022 /PRNewswire-PRWeb/ -- Worldwide, an estimated 26% of women have chronic pelvic pain (CPP). In the US, it's the reason for 40% of laparoscopies and 12% of hysterectomies annually, even though, in 80% of the patients, the origin of the pain is not gynecologic![1] Up to a third of women have repeated absences from work due to their pain.[2] One study found that 15% of US women of childbearing age say their pelvic pain has lasted at least 6 months.[3]

Key Points: 
  • [2] One study found that 15% of US women of childbearing age say their pelvic pain has lasted at least 6 months.
  • At the PAINWeek National Conference, September 6-9 at The Cosmopolitan of Las Vegas, the IPPSInternational Pelvic Pain SocietyTrack will provide the resources and knowledge to help attendees better understand pelvic pain.
  • The IPPS Track on Thursday, September 8, will include Dr. Georgine Lamvu presenting One Candle, Two Wicks: Managing Female Sexual Pain and Dysfunction.
  • Dr. Lamvu commented, "gender specific pain conditions, such as endometriosis and female sexual pain, contribute their own unique complexity to the evaluation and management of chronic pain.